167 related articles for article (PubMed ID: 25262804)
1. Revisiting de novo drug design: receptor based pharmacophore screening.
Amaravadhi H; Baek K; Yoon HS
Curr Top Med Chem; 2014; 14(16):1890-8. PubMed ID: 25262804
[TBL] [Abstract][Full Text] [Related]
2. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
Tanrikulu Y; Schneider G
Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
[TBL] [Abstract][Full Text] [Related]
3. Library design and virtual screening using multiple 4-point pharmacophore fingerprints.
Mason JS; Cheney DL
Pac Symp Biocomput; 2000; ():576-87. PubMed ID: 10902205
[TBL] [Abstract][Full Text] [Related]
4. From activity cliffs to target-specific scoring models and pharmacophore hypotheses.
Seebeck B; Wagener M; Rarey M
ChemMedChem; 2011 Sep; 6(9):1630-9, 1533. PubMed ID: 21751401
[TBL] [Abstract][Full Text] [Related]
5. NMR-based screening methods for lead discovery.
Vogtherr M; Fiebig K
EXS; 2003; (93):183-202. PubMed ID: 12613177
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore based drug design approach as a practical process in drug discovery.
Gao Q; Yang L; Zhu Y
Curr Comput Aided Drug Des; 2010 Mar; 6(1):37-49. PubMed ID: 20370694
[TBL] [Abstract][Full Text] [Related]
7. Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling.
Dong X; Ebalunode JO; Yang SY; Zheng W
Curr Comput Aided Drug Des; 2011 Sep; 7(3):181-9. PubMed ID: 21726192
[TBL] [Abstract][Full Text] [Related]
8. 2-D and 3-D modeling of imidazoline receptor ligands: insights into pharmacophore.
Carrieri A; Brasili L; Leonetti F; Pigini M; Giannella M; Bousquet P; Carotti A
Bioorg Med Chem; 1997 May; 5(5):843-56. PubMed ID: 9208096
[TBL] [Abstract][Full Text] [Related]
9. Design of libraries to explore receptor sites.
Murray CM; Cato SJ
J Chem Inf Comput Sci; 1999; 39(1):46-50. PubMed ID: 10094612
[TBL] [Abstract][Full Text] [Related]
10. A pseudo-ligand approach to virtual screening.
Schüller A; Fechner U; Renner S; Franke L; Weber L; Schneider G
Comb Chem High Throughput Screen; 2006 Jun; 9(5):359-64. PubMed ID: 16787149
[TBL] [Abstract][Full Text] [Related]
11. Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design.
Dror O; Shulman-Peleg A; Nussinov R; Wolfson HJ
Curr Med Chem; 2004 Jan; 11(1):71-90. PubMed ID: 14754427
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in de novo design strategy for practical lead identification.
Honma T
Med Res Rev; 2003 Sep; 23(5):606-32. PubMed ID: 12789688
[TBL] [Abstract][Full Text] [Related]
13. The selection and design of GPCR ligands: from concept to the clinic.
Ashton M; Charlton MH; Schwarz MK; Thomas RJ; Whittaker M
Comb Chem High Throughput Screen; 2004 Aug; 7(5):441-52. PubMed ID: 15320711
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based virtual screening.
Horvath D
Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
[TBL] [Abstract][Full Text] [Related]
15. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
[TBL] [Abstract][Full Text] [Related]
16. Computational protein-ligand docking and virtual drug screening with the AutoDock suite.
Forli S; Huey R; Pique ME; Sanner MF; Goodsell DS; Olson AJ
Nat Protoc; 2016 May; 11(5):905-19. PubMed ID: 27077332
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
Yang SY
Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
[TBL] [Abstract][Full Text] [Related]
18. On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches.
Huang D; Gu Q; Ge H; Ye J; Salam NK; Hagler A; Chen H; Xu J
J Chem Inf Model; 2012 May; 52(5):1356-66. PubMed ID: 22545675
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore modelling: a forty year old approach and its modern synergies.
Caporuscio F; Tafi A
Curr Med Chem; 2011; 18(17):2543-53. PubMed ID: 21568893
[TBL] [Abstract][Full Text] [Related]
20. Pocket v.2: further developments on receptor-based pharmacophore modeling.
Chen J; Lai L
J Chem Inf Model; 2006; 46(6):2684-91. PubMed ID: 17125208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
